ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,193Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 99

$717K Total Retail Price of All Prescriptions

Rank: 3 out of 99

671 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 671 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 671 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 7,669 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
ALLOPURINOL 983 708 10 1 16
PRAVASTATIN SODIUM 657 451 2 15
LISINOPRIL 612 446 3 5
BUMETANIDE 538 396 4 45
DOXAZOSIN MESYLATE 508 405 5 35
AMLODIPINE BESYLATE 409 270 6 4
HYDROCODONE-ACETAMINOPHEN 339 91 S3 7 1
CALCITRIOL 292 197 8 47
FUROSEMIDE 246 171 9 7
SIMVASTATIN 246 211 9 3
LEVOTHYROXINE SODIUM 220 191 11 6
LOSARTAN POTASSIUM 216 149 12 19
POTASSIUM CHLORIDE 204 183 13 18
OMEPRAZOLE 199 88 14 2
CARVEDILOL 162 111 15 21
TERAZOSIN HCL 159 118 16 44
GLYBURIDE 157 129 R 17 107
HYDROCHLOROTHIAZIDE 155 115 18 22
METOPROLOL TARTRATE 149 90 19 20
PREDNISONE 141 69 20 10
ATORVASTATIN CALCIUM 136 52 21 23
METOPROLOL SUCCINATE 134 93 22 13
SENSIPAR 133 38 23 50
GABAPENTIN 127 64 24 9
CITALOPRAM HBR 121 52 25 36
ZOLPIDEM TARTRATE 115 57 26 63
DIOVAN 113 60 27 75
LANTUS 112 36 28 38
METOCLOPRAMIDE HCL 112 44 28 53
ATENOLOL 112 80 28 25
METOLAZONE 109 75 31 124
NOVOLOG 109 65 31 65
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 43 33 157
CLONIDINE HCL 100 64 34 93
CALCIUM ACETATE 99 30 35 73
ALENDRONATE SODIUM 89 64 36 28
CIPROFLOXACIN HCL 85 64 37 40
TRAMADOL HCL 79 57 38 30
MIRTAZAPINE 79 46 38 93
WARFARIN SODIUM 77 34 40 17
KLOR-CON M20 77 57 40 130
METFORMIN HCL 75 59 42 26
RENVELA 62 18 43 68
NOVOLOG FLEXPEN 61 27 44 101
CYCLOBENZAPRINE HCL 60 24 R 45 150
MINOXIDIL 59 54 46 132
MIDODRINE HCL 55 14 47 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.